Find clinical trials for Prostate Cancer in Austin, TX
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Austin, TX, USA:
Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, pros...
Austin, Texas, United States and 38 other locations
Assessment of the safety and efficacy of HLD-0915 as monotherapy in patients with metastatic castration resistant prostate cancer (...
Phase 1, Phase 2
Austin, Texas, United States and 10 other locations
radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stim...
Phase 3
Austin, Texas, United States and 72 other locations
with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....
Phase 3
Austin, Texas, United States and 321 other locations
of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate...
Austin, Texas, United States and 25 other locations
for the possible treatment of Relapsed/ Refractory Small Cell Lung Cancer (SCLC), Castration Resistant Prostate Cancer (CR...
Phase 1
Austin, Texas, United States and 83 other locations
plus docetaxel in participants with metastatic castration resistant prostate cancer (mCRPC), all participants will receive the doce...
Phase 3
Austin, Texas, United States and 216 other locations
compare the efficacy and safety of BMS-986365 versus the investigator's choice of therapy in participants with Metastatic Castration-resistant Prostate...
Phase 3
Austin, Texas, United States and 279 other locations
prior abiraterone defined as:* Abiraterone started in hormone-sensitive prostate cancer (HSPC) disease setting: \< 12 months durat ...
Phase 2
Austin, Texas, United States and 30 other locations
This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of vudalimab (XmAb20717) in...
Phase 2
Austin, Texas, United States and 16 other locations
Clinical trials
Research sites
Resources
Legal